Jefferies Maintains a 'Buy' on Incyte (INCY); Despite CCO Leaving, Focus Remains on Jakafi

Article Related Articles (2) Stock Quotes (1) Comments (0)

Jefferies maintains a 'Buy' on Incyte (NASDAQ: INCY) price target of $31.00.

Analyst, Thomas Wei, said, "In an 8-K released Wednesday, INCY disclosed that Chief Commercial Officer Patricia Andrews left the company. Despite the change, we remain positive on the Jakafi sales trajectory as weekly new patient starts remain constant and the discontinuation rate continues to improve as less sick patients are started on therapy."

For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.

Shares of Incyte closed at $19.92 yesterday, with a 52 week range of $11.76-$26.30.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Compass Point Boosts Numbers on RLJ Lodging Trust (RLJ)
• Deutsche Bank Raises PT on Access Midstream Partners (ACMP) to $57

Create E-mail Alert Related Categories

Analyst Comments, Management Changes

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?